| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.083 | 0.2 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.33 | 0.3 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |